OverviewChartNews

Claims of enterprises on non-residents arisin.../  Deutsche Bundesbank

- - Chg. - Open High Low Previous Close
-EUR - - - - -
TeleTrader 08:39 Trump starts TikTok account
GlobeNewswire 08:00 ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth
TeleTrader 07:46 Ukraine says Russia lost over 1,000 troops in a day
TeleTrader 06:51 US, South Korea slam North's 'provocations'
TeleTrader 06:03 Iran summons Swedish envoy over attacks report
TeleTrader 05:14 US destroys two Houthi ballistic missiles
TeleTrader 04:25 China's restraint over Philippines 'has limits'
TeleTrader 03:34 North Korea sends 600 balloons carrying trash to South
GlobeNewswire 03:00 BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fil...
TeleTrader 02:48 Jose Mourinho to be manager of Fenerbahce
Newsfile Corp 02:24 OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaka' at the UEFA Champions Leagu...
GlobeNewswire 02:15 Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champio...
TeleTrader 01:59 Houthis say they targeted US vessels
TeleTrader 01:11 China lands Chang'e-6 spacecraft on Moon
TeleTrader 01:06 Ben-Gvir warns he will 'dismantle' govt if Israel makes ceasefire deal
TeleTrader 00:15 53 people arrested at Champions League final
TeleTrader 00:03 Real Madrid wins Champions League
TeleTrader 01/06 Weekly Recap: Trump's legal woes, ceasefire proposal, Rafah strike reactions
TeleTrader 01/06 Boeing's Starliner launch delayed again due to technical glitch
GlobeNewswire 01/06 First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process
TeleTrader 01/06 Israel's Gantz calls for war cabinet meeting
TeleTrader 01/06 Al-Quds claim attack on Israel in Rafah
GlobeNewswire 01/06 QuidelOrtho (QDEL) Investors Who Suffered Substantial Losses After QDEL Reported Disastrous Q4 2023 ...
TeleTrader 01/06 US upset by Israel's response to Biden's ceasefire proposal
GlobeNewswire 01/06 Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pret...